These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22931754)

  • 1. Genetic animal models for evaluating the role of autophagy in etiopathogenesis of Parkinson disease.
    Lachenmayer ML; Yue Z
    Autophagy; 2012 Dec; 8(12):1837-8. PubMed ID: 22931754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of α-synuclein and LRRK2 in the brain.
    Friedman LG; Lachenmayer ML; Wang J; He L; Poulose SM; Komatsu M; Holstein GR; Yue Z
    J Neurosci; 2012 May; 32(22):7585-93. PubMed ID: 22649237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic mutations in Parkinson disease.
    Tan EK; Skipper LM
    Hum Mutat; 2007 Jul; 28(7):641-53. PubMed ID: 17385668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What genetics tells us about the causes and mechanisms of Parkinson's disease.
    Corti O; Lesage S; Brice A
    Physiol Rev; 2011 Oct; 91(4):1161-218. PubMed ID: 22013209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
    Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
    Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic dysfunction in genetic models of Parkinson's disease: a role for autophagy?
    Plowey ED; Chu CT
    Neurobiol Dis; 2011 Jul; 43(1):60-7. PubMed ID: 20969957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant Twinkle increases dopaminergic neurodegeneration, mtDNA deletions and modulates Parkin expression.
    Song L; Shan Y; Lloyd KC; Cortopassi GA
    Hum Mol Genet; 2012 Dec; 21(23):5147-58. PubMed ID: 22949510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review.
    Chen ML; Wu RM
    J Biomed Sci; 2018 Jun; 25(1):52. PubMed ID: 29903014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atg1-mediated autophagy suppresses tissue degeneration in
    Ma P; Yun J; Deng H; Guo M
    Mol Biol Cell; 2018 Dec; 29(26):3082-3092. PubMed ID: 30354903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical molecular genetics for PARK8 (LRRK2)].
    Tomiyama H; Hatano T; Hattori N
    Brain Nerve; 2007 Aug; 59(8):839-50. PubMed ID: 17713120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.
    Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z
    J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.
    Chen L; Xie Z; Turkson S; Zhuang X
    J Neurosci; 2015 Jan; 35(3):890-905. PubMed ID: 25609609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
    Trancikova A; Tsika E; Moore DJ
    Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Function study advances of Parkinson disease related genes].
    Wang XM; Wang DQ; Wang XY
    Yi Chuan; 2010 Aug; 32(8):779-84. PubMed ID: 20709674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Parkinson's disease using induced pluripotent stem cells.
    Byers B; Lee HL; Reijo Pera R
    Curr Neurol Neurosci Rep; 2012 Jun; 12(3):237-42. PubMed ID: 22538490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.